Who makes [14C]-GLPG1690 capsules?

[14C]-GLPG1690 capsules is developed by Galapagos NV.

What development phase is [14C]-GLPG1690 capsules in?

[14C]-GLPG1690 capsules is in Phase 1.

Last reviewed 2026-04-19 · How we verify

[14C]-GLPG1690 capsules

Galapagos NV · Phase 1 active Small molecule

At a glance

Generic name	[14C]-GLPG1690 capsules
Sponsor	Galapagos NV
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-GLPG1690 capsules CI brief — competitive landscape report
[14C]-GLPG1690 capsules updates RSS · CI watch RSS
Galapagos NV portfolio CI